Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-183-8 | CAS number: 12124-97-9
Endpoint summary
Administrative data
Description of key information
Ammonium bromide is considered not to be a sensitiser (0/20 sensitisation rate) in a guinea pig maximisation study.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997-08-04 to 1997-09-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted prior to existance of OECD 429 (LLNA) testing guidelines
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Darley Oarks, Newchurch, Staffordshire, United Kingdom
- Age at study initiation: less than one year
- Weight at study initiation: 299-321 g
- Housing: in aluminium cages (48 x 61 x 25 cm) with a grid floor (dose-range finding: 2 per cage, main study: 5 per cage)
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 20°C
- Humidity (%): mean: 67%
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12 hour light/dark cycle
IN-LIFE DATES: From: 1997-08-04 To: 1997-09-05 - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction:
5% test substance for intradermal injection,
55% test substance for topical application (maximum practicable concentration)
Challenge:
55% test substance for topical application (maximum practicable concentration) - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Induction:
5% test substance for intradermal injection,
55% test substance for topical application (maximum practicable concentration)
Challenge:
55% test substance for topical application (maximum practicable concentration) - No. of animals per dose:
- 20 in test group
10 in control group - Details on study design:
- RANGE FINDING TESTS:
Two animals each were used in the dose range finding phase for the selection of appropriate concentrations for intradermal and topical induction.
Dose range finding for induction:
Dose ranging for induction was conducted via intradermal injections and topical application of formulations of the test material. For the dose range finding study, hair was clipped from an area of the scapular region (intradermal injection of 1, 2, 5 or 10% ammonium bromide solution) or of both flanks (topical induction with 25, 40, 50 or 55% ammonium bromide solution) of the animals on the day prior to administration.
Dose ranging for challenge:
Concentrations used took account of the maximum practicable concentration for administration. Three weeks prior to administration of the test material, hair was clipped from an area across the scapular region of the animals. On the following day, each animal was treated via intradermal injection.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Two
- Exposure period: day 0 intradermal injection, day 7 topical application
- Control group: 2-mercaptobenzothizole (MBT) as the positive control substance
- Site: scapula region
- Duration: Removal of test substance 48 hours after topical application with sterile distilled water.
- Concentrations: 5% test substance for intradermal injection, 55% test substance for topical application
B. CHALLENGE EXPOSURE
- No. of exposures: One
- Day(s) of challenge: day 21 topical application
- Exposure period: Removal of test substance 48 hours after topical application with sterile distilled water
- Site: scapula region
- Concentrations: 55% test substance
- Evaluation (hr after challenge): 24h, 48h after challenge; dermal reactions were also assessed 24h after intradermal and topical induction application.
OTHER:
- FCA was prepared as a 50% v/v emulsion with sterile distilled water - Positive control substance(s):
- yes
- Remarks:
- 2-mercaptobenzothizole (MBT)
- Positive control results:
- For positive control, animals were treated with MBT at a dose level of 75% w/v in maize oil. Following challenge, 100% of test group animals and none of the control group animals reacted positively. This demonstrates the ability of the test method to identify a mild/moderate sensitizer.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 % / 55 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 % / 55 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 5 %/ 75 %
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- -
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Based on results of 6-monthly check
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 5 %/ 75 %
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- -
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of the study, ammonium bromide is considered not to be a sensitizer (0/20 sensitisation rate) in guinea pigs. In accordance with CLP Regulation (EC) No 1272/2008, no classification and labelling with respect to skin sensitisation is required.
- Executive summary:
Materials and Methods
The objective of the study was to determine the delayed contact hypersensitivity of ammonium bromide using the protocol of the Magnusson-Kligman Maximisation Test in guinea pigs. The induction procedure for the test group of 20 guinea pigs consisted of exposure to the test material via two routes, intradermal injection (5% ammonium bromide) and topical application (55% ammonium bromide; the maximum practicable concentration). Animals were also exposed to an adjuvant via intradermal injection. The control group was exposed to vehicle, sterile distilled water, only. Prior to a topical challenge application with 55% ammonium bromide, all animals were treated with a 10% SLS solution the day before. The appropriate concentrations for intradermal injection and topical induction as well as for the topical challenge application were selected in a dose range finding study.
Results and Discussion
Prior to challenge, 2 animals (1 test group, 1 control group) were humanely killed as the condition of their scapular region had exceeded the severity limit set by the project licence governing the study. Following challenge no positive responses were observed in any of the remaining control or test group animals after challenge with 55% ammonium bromide.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1988
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: D. Hall, Newchurch, Staffordshire, England
- Age at study initiation: Not indicated
- Weight at study initiation: 301-374g - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction:
7.5% w/w sodium bromide, technical grade in water (intradermal injection)
30% w/w sodium bromide, technical grade in water (topical application)
Challenge:
5% and 10% w/w sodium bromide, technical grade in water - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Induction:
7.5% w/w sodium bromide, technical grade in water (intradermal injection)
30% w/w sodium bromide, technical grade in water (topical application)
Challenge:
5% and 10% w/w sodium bromide, technical grade in water - No. of animals per dose:
- 20 in test group
20 in control group - Details on study design:
- RANGE FINDING TESTS:
The irritancy of a range of dilutions following intradermal and topical application was investigated for the selection of suitable irritant concentrations for induction and non-irritant concentrations for challenge.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Two
- Exposure period: day 0 intradermal injection, day 7 topical application
- Site: scapular region
- Duration: 24 h for topical application
- Concentrations: 7.5% w/w sodium bromide, technical grade in water (intradermal injection), 30% w/w sodium bromide, technical grade in water (topical application)
B. CHALLENGE EXPOSURE
- No. of exposures: One
- Day(s) of challenge: day 21
- Exposure period: 24 hours
- Site: scapular region
- Concentrations: 5% and 10% w/w sodium bromide, technical grade in water
- Evaluation (hr after challenge): 24h, 48h and 72h after challenge
OTHER:
Concentration Freunds Complete Adjuvant (FCA): 50% in water - Positive control substance(s):
- yes
- Remarks:
- Formalin
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 7.5 % / 30 %, 10 % / 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 7.5 % / 30 %, 10 % / 5 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical signs .
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 7.5 % / 30 %, 10 % / 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 7.5 % / 30 %, 10 % / 5 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical signs .
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical signs .
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no clinical signs .
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In this screening test performed with twenty guinea pigs, sodium bromide, technical grade did not produce evidence of delayed contact hypersensitivity. The test substance does not have to be classified and labelled with respect to skin sensitisation.
- Executive summary:
Materials and Methods
The study was designed to assess skin sensitisation potential of Sodium Bromide, technical grade. The intradermal and topical irritancy of a range of dilutions of sodium bromide, technical grade was investigated to identify (a) irritant test substance concentrations suitable for the induction phase of the main study and (b) non-irritant concentrations by the topical route of administration for the challenge phase. Based on the results of this preliminary investigation concentrations of sodium bromide for the main study were selected. For the main study twenty guinea pigs were treated with the test substance intracutaneously (day 0) and epicutaneously (day 7) for induction and epicutaneously (day 21) for challenge.
Results and Discussion
The dermal reactions seen in the test animals are similar to those seen in the control animals.
Referenceopen allclose all
Result of pilot study:
Intradermal Injection:
For the selection of appropriate concentrations for induction, intense reactions were noted at a concentration of 10% ammonium bromide. Discrete to moderate reactions were noted at concentrations of 1, 2 and 5% ammonium bromide. No reactions were seen after challenge.
Topical Application:
No reactions were noted at concentrations up to 55% ammonium bromide both for the selection of inducation and challenge concentration. Animals pretreated with Sodium Lauryl Sulphate showed dry and/or flaky and scabbed test sites after challenge application.
Overall result (main study):
No positive skin responses were noted following induction or challenge and no skin sensitising potential could be identified.
Body weight performance was considered to have been satisfactory.
Two animals /1 test group and 1 control group), were humanely killed before challenge as the condition of their scapular region had exceeded the severity limit set by the project licence governing the study. There were no other clinical signs, other than skin reactions, noted.
There were no premature deaths noted.
Table A6.1.5/01-1 Result of skin sensitisation pretest with Ammonium Bromide |
||||||||
Application method |
Concentration |
Skin reaction after intracutaneous or epicutaneous application |
|
|||||
Animal no. 1 |
Animal no. 2 |
|
||||||
24h |
48h |
72h |
24h |
48h |
72h |
|
||
intracutaneous |
10 |
3 |
3 |
3 |
3 |
3 |
3 |
|
5 |
2 |
2 |
2 |
1 1 |
1 |
0 |
|
|
2 |
1 |
1 |
0 |
1 |
0 |
0 |
|
|
1 |
0 |
0 |
0 |
1 |
0 |
0 |
|
|
epicutaneous |
|
Animal no. 3 |
Animal no. 4 |
|
||||
55 |
0a |
0a |
n.d. |
0 |
0 |
n.d. |
|
|
50 |
0 |
0 |
n.d. |
0 |
0 |
n.d. |
|
|
40 |
0 |
0 |
n.d. |
0 |
0 |
n.d. |
|
|
25 |
0 |
0 |
n.d. |
0 |
0 |
n.d. |
|
|
0= no visible change
1= discrete or patchy erythema
2= moderate and confluent erythema
3= intense erythema and swelling
a= scabbing on test site
n.d.= not determined
Table A6.1.5/01-2 Result of intradermal induction with Ammonium Bromide (main study)
Group and concentration (% ammonium bromide) |
Animal number |
Reaction Scores 24 hours after injection |
Control (0) |
1 |
0 |
2 |
0 |
|
3 |
0 |
|
4 |
0 |
|
5 |
0 |
|
6 |
0 |
|
7 |
0 |
|
8 |
0 |
|
9 |
0 |
|
10 |
0 |
|
Test (5) |
1 |
0 |
2 |
0 |
|
3 |
0 |
|
4 |
0 |
|
5 |
0 |
|
6 |
0 |
|
7 |
0 |
|
8 |
0 |
|
9 |
0 |
|
10 |
0 |
|
11 |
0 |
|
12 |
0 |
|
13 |
0 |
|
14 |
0 |
|
15 |
0 |
|
16 |
0 |
|
17 |
0 |
|
18 |
0 |
|
19 |
0 |
|
20 |
0 |
Table A6.1.5/01-3 Result of topical induction with Ammonium Bromide (main study)
Group and concentration (% ammonium bromide) |
Animal number |
Reaction Scores 24 hours after injection |
Control (0) |
1 |
0 |
2 |
0 |
|
3 |
0 |
|
4 |
0 |
|
5 |
0 |
|
6 |
0 |
|
7 |
0 |
|
8 |
0 |
|
9 |
0 |
|
10 |
0 |
|
Test (55) |
1 |
0 |
2 |
0 |
|
3 |
0 |
|
4 |
0 |
|
5 |
0 |
|
6 |
0 |
|
7 |
0 |
|
8 |
0 |
|
9 |
0 |
|
10 |
0 |
|
11 |
0 |
|
12 |
0 |
|
13 |
0 |
|
14 |
0 |
|
15 |
0 |
|
16 |
0 |
|
17 |
0 |
|
18 |
0 |
|
19 |
0 |
|
20 |
0 |
Table A6.1.5/01-4 Result of challenge with Ammonium Bromide (main study)
group |
Animal number |
Concentration ammonium bromide (%)/ Time after patch removal |
Concentration (% ammonium bromide)/response |
Concentration (% ammonium bromide)/ % positive |
|||||
55 |
0 |
||||||||
24h |
48h |
24h |
48h |
55 |
0 |
55 |
0 |
||
control |
1 |
0 |
0 |
0 |
0 |
- |
- |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
- |
- |
|||
3 |
0 |
0 |
0 |
0 |
- |
- |
|||
4 |
0 |
0 |
0 |
0 |
- |
- |
|||
5 |
0 |
0 |
0 |
0 |
- |
- |
|||
6 |
0 |
0 |
0 |
0 |
- |
- |
|||
7 |
0 |
0 |
0 |
0 |
- |
- |
|||
8 |
0 |
0 |
0 |
0 |
- |
- |
|||
9 |
0 |
0 |
0 |
0 |
- |
- |
|||
10 |
a |
a |
a |
a |
a |
a |
|||
test |
1 |
0 |
0 |
0 |
0 |
- |
- |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
- |
- |
|||
3 |
0 |
0 |
0 |
0 |
- |
- |
|||
4 |
0 |
0 |
0 |
0 |
- |
- |
|||
5 |
0 |
0 |
0 |
0 |
- |
- |
|||
6 |
0 |
0 |
0 |
0 |
- |
- |
|||
7 |
0 |
0 |
0 |
0 |
- |
- |
|||
8 |
0 |
0 |
0 |
0 |
- |
- |
|||
9 |
0 |
0 |
0 |
0 |
- |
- |
|||
10 |
0 |
0 |
0 |
0 |
- |
- |
|||
11 |
0 |
0 |
0 |
0 |
- |
- |
|||
12 |
0 |
0 |
0 |
0 |
- |
- |
|||
13 |
0 |
0 |
0 |
0 |
- |
- |
|||
14 |
0 |
0 |
0 |
0 |
- |
- |
|||
15 |
a |
a |
a |
a |
a |
a |
|||
16 |
0 |
0 |
0 |
0 |
- |
- |
|||
17 |
0 |
0 |
0 |
0 |
- |
- |
|||
18 |
0 |
0 |
0 |
0 |
- |
- |
|||
19 |
0 |
0 |
0 |
0 |
- |
- |
|||
20 |
0 |
0 |
0 |
0 |
- |
- |
|||
- Negative
a Animal dead before assessment
Result of pilot study:
Intradermal injection of different concentrations of sodium bromide resulted in slight to mild oedema and slight to necrotic erythema (see table 6.1.5/02-1).
Topical application of 5, 10, 20 and 30 % sodium bromide, technical grade showed localized dermal reactions in one of the animals treated with 20% of test substance. This reaction was reversible and skin appeared normal by 24 hours after treatment. All other animals did not show reactions after treatment.
Based on the results of the preliminary investigations, concentrations of 7.5% (w/w) and 30% (w/w) were selected for intradermal and topical induction and 10% and 5% (w/w) for topical challenge application.
Overall result of main study:
Sodium bromide, technical grade did not produce evidence of delayed contact hypersensitivity
Table A6.1.5/02-1 Results of pre-test with Sodium Bromide, technical grade, intradermal injection
|
||||||
Guinea-pig number |
Concentration [% w/w]
|
|
Score |
|
||
|
1 |
2 |
|
|||
4674/4679 |
10 |
D E O |
8/12 N/N 2/2 |
8/10 N/N 2/2 |
|
|
7.5 |
D E O |
8/10 2/2 1/1 |
8/10 1/1 1/1 |
|
||
5 |
D E O |
6/8 2/2 1/1 |
6/6 1/1 2/2 |
|
||
2.5 |
D E O |
6/6 2/2 1/1 |
6/6 1/1 1/1 |
|
||
1 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.5 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.25 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.1 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
vehicle control (water) |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
D: Diameter (mm)
E: Erythema (0-4 numerical scores)
O: Oedema (0-4 numerical scores)
N: Necrosis
1: score assessed day of injection
2: score assessed day 3 after injection
Table A6.1.5/02-2 Results of main study with Sodium Bromide, technical grade, challenge application
Treatment |
Guinea-pig number |
Erythema (E) Oedema (O) |
Score |
Results |
|||||
24 h |
48 h |
72 h |
|||||||
A |
P |
A |
P |
A |
P |
||||
Freund´s Treated control |
5590 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
5591 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5592 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5593 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5594 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5595 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5596 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5597 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5598 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5599 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5560 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5501 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5502 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5503 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5504 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5505 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5506 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5507 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5508 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5509 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
Test |
5510 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
5511 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5512 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5513 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5514 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5515 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5516 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5517 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5518 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5519 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5520 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5521 |
E O |
L1 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5522 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5523 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5524 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5525 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5526 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5527 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5528 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5529 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
A Anterior site, exposed to 10% w/w sodium bromide, technical grade in distilled water
P Posterior site, exposed to 5% w/w sodium bromide, technical grade in distilled water
L1 Localized dermal reaction, restricted to a small area of the challenge site
Results: + positive
- negative
+/- inconclusive
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The objective of the study was to determine the delayed contact hypersensitivity of ammonium bromide using the protocol of the Magnusson-Kligman Maximisation Test in guinea pigs. The induction procedure for the test group of 20 guinea pigs consisted of exposure to the test material via two routes, intradermal injection (5% ammonium bromide) and topical application (55% ammonium bromide; the maximum practicable concentration). Animals were also exposed to an adjuvant via intradermal injection. The control group was exposed to vehicle, sterile distilled water, only. Prior to a topical challenge application with 55% ammonium bromide, all animals were treated with a 10% SLS solution the day before. The appropriate concentrations for intradermal injection and topical induction as well as for the topical challenge application were selected in a dose range finding study.
Prior to challenge, 2 animals (1 test group, 1 control group) were humanely killed as the condition of their scapular region had exceeded the severity limit set by the project licence governing the study. Following challenge no positive responses were observed in any of the remaining control or test group animals after challenge with 55% ammonium bromide.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the experimental results of the Guinea pig maximisation test, ammonium bromide is not classified for sensitization.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
